Cigna Group (CI) Stock Forecast & Price Target

$283.76 +1.78 (+0.63%)

Closing price 05/7/2026 03:59 PM Eastern

Extended Trading

$283.86 +0.11 (+0.04%)

As of 07:39 AM Eastern

Compare

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 21 Analyst Ratings

Sell
0

Hold
4

Buy
17

Based on 21 Wall Street analysts who have issued ratings for Cigna Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 4 have given a hold rating, 16 have given a buy rating, and 1 has given a strong buy rating for CI.

Consensus Price Target

$338.35
19.24% Upside

According to the 21 analysts' twelve-month price targets for Cigna Group, the average price target is $338.35. The highest price target for CI is $375.00, while the lowest price target for CI is $297.00. The average price target represents a forecasted upside of 19.24% from the current price of $283.76.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cigna Group and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CI Analyst Ratings Over Time

Type	Current Forecast 5/8/25 to 5/8/26	1 Month Ago 4/8/25 to 4/8/26	3 Months Ago 2/7/25 to 2/7/26	1 Year Ago 5/8/24 to 5/8/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	16 Buy rating(s)	17 Buy rating(s)	15 Buy rating(s)	16 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$338.35	$333.11	$323.16	$378.22
Forecasted Upside	19.24% Upside	20.03% Upside	10.56% Upside	13.46% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cigna Group Stock vs. The Competition

Type	Cigna Group	Medical Companies	S&P 500
Consensus Rating Score	2.86	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	19.24% Upside	841.15% Upside	14.94% Upside
News Sentiment Rating	Positive News See Recent CI News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/5/2026	Sanford C. Bernstein 4 of 5 stars	Lance Wilkes Not Rated	Boost Target	Outperform	$358.00 ➝ $371.00	+32.72%
5/4/2026	Guggenheim 5 of 5 stars	Jason Cassorla 3 of 5 stars	Boost Target	Buy	$334.00 ➝ $338.00	+19.09%
5/4/2026	The Goldman Sachs Group 3 of 5 stars		Boost Target	Buy	$335.00 ➝ $340.00	+20.08%
5/1/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$340.00	+20.01%
5/1/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$325.00 ➝ $340.00	+19.68%
5/1/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$337.00	+18.63%
5/1/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$330.00	+16.16%
5/1/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$303.00 ➝ $310.00	+6.68%
5/1/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$333.00 ➝ $337.00	+19.19%
5/1/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$300.00 ➝ $305.00	+6.85%
Get the Latest News and Ratings for CI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cigna Group and its competitors with MarketBeat's FREE daily newsletter.
4/20/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$333.00 ➝ $330.00	+18.58%
3/3/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$374.00 ➝ $370.00	+30.99%
2/17/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$320.00 ➝ $350.00	+20.13%
2/10/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$301.00 ➝ $304.00	+3.73%
2/9/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$375.00	+29.04%
2/9/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Rhyee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$333.00 ➝ $338.00	+14.97%
2/6/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Market Perform	$270.00 ➝ $297.00	+2.82%
1/5/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
12/29/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C-)
11/4/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$428.00 ➝ $375.00	+42.26%
10/31/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$355.00	+44.51%
10/15/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$345.00 ➝ $325.00	+10.74%
1/31/2025	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$400.00 ➝ $375.00	+26.31%
1/31/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raj Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$410.00 ➝ $380.00	+28.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:40 AM ET.

Should I Buy Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 6, 2026. Please send any questions or comments about these Cigna Group pros and cons to contact@marketbeat.com.

Cigna Group
Bull Case

Here are some ways that investors could benefit from investing in The Cigna Group:

Analyst sentiment remains largely positive, with multiple buy ratings and a median price target around $334, suggesting potential upside from current levels if the company continues to execute effectively.
The Cigna Group's recent earnings report showed a strong performance from its Evernorth unit, which supports durable service-fee revenue, indicating a solid foundation for future growth.
The current stock price is approximately $288, which may be seen as an attractive entry point for investors looking for value in the healthcare sector.
Recent strategic reviews indicate that The Cigna Group is actively pursuing alternatives for its eviCore unit, which could lead to beneficial restructuring or asset sales, potentially enhancing overall company value.
With a diverse portfolio of healthcare products and insurance solutions, The Cigna Group serves a wide range of customers, including commercial, Medicare, and Medicaid, which helps mitigate risks associated with market fluctuations.

Cigna Group
Bear Case

Investors should be bearish about investing in The Cigna Group for these reasons:

The Cigna Group's decision to exit the Affordable Care Act individual market in 2027 could impact approximately 369,000 members, reducing future premium revenue and potentially alarming investors focused on top-line growth.
There are ongoing pressures related to pharmacy benefit management costs, with higher drug prices posing a risk to profit margins if not effectively managed through pricing strategies or cost controls.
Recent insider trading activity, including significant stock sales by company insiders, may raise concerns about the confidence of those closest to the company regarding its future performance.
While the company has received upgrades from analysts, some have also lowered their target prices, indicating mixed sentiment that could create uncertainty for potential investors.
Management's strategic review of eviCore introduces uncertainty regarding the timing and outcomes of potential asset sales or restructuring, which could affect investor confidence in the company's direction.

CI Forecast - Frequently Asked Questions

: According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Cigna Group is $338.35, with a high forecast of $375.00 and a low forecast of $297.00.
: 21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cigna Group in the last twelve months. There are currently 4 hold ratings, 16 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CI shares.
: According to analysts, Cigna Group's stock has a predicted upside of 19.24% based on their 12-month stock forecasts.
: Over the previous 90 days, Cigna Group's stock had 1 upgrade by analysts.
: Cigna Group has been rated by research analysts at Barclays, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group, Mizuho, Piper Sandler, Raymond James Financial, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Cigna Group more than other "medical" companies. The consensus rating for Cigna Group is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cigna Group Recommendations

This page (NYSE:CI) was last updated on 5/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cigna Group (CI) Stock Forecast & Price Target

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CI Analyst Ratings Over Time

CI Analyst Recommendations By Month

CI Price Targets by Month

Cigna Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Cigna Group Stock? CI Pros and Cons Explained

Cigna Group
Bull Case

Cigna Group
Bear Case

CI Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cigna Group Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cigna Group (CI) Stock Forecast & Price Target

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CI Analyst Ratings Over Time

CI Analyst Recommendations By Month

CI Price Targets by Month

Cigna Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Cigna Group Stock? CI Pros and Cons Explained

Cigna Group Bull Case

Cigna Group Bear Case

CI Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cigna Group Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Cigna Group
Bull Case

Cigna Group
Bear Case